Search Results 61-70 of 43493 for Two-phase

  1. Phase 2 Study Of VGT-309 In Lung Cancer - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  2. Study Is To Assess The Safety And Tolerability Of VTx-002 In Participants With ALS - Mayo Clinic

    PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose ... Two escalating dose (low dose and high dose) cohorts are planned. The duration ...

  3. Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer - Mayo Clinic

    Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer · More about research at Mayo ...

  4. centers-of-excellence

    Overview Tab Title Description Study type Interventional Study phase 2 Study IDs Study type Interventional Describes the nature of a ...

  5. Hematology - Clinical trials

    This phase III trial studies whether inotuzumab ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

  6. A Phase 1/​2 Study of STP938 for Adult Subjects With Relapsed/​Refractory B-Cell and T-Cell Lymphomas - Mayo Clinic

    Clinical Trials · A Phase 1/​2 Study of STP938 for Adult Subjects With Relapsed/​Refractory B-Cell and T-Cell Lymphomas · More about research at Mayo Clinic · Mayo ...

  7. PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. A Dose-Ranging Study to Determine the Effectiveness, Safety and Tolerability of AeroFact - Mayo Clinic

    The purpose of this two-part Phase 2 study is to assess the safety, tolerability and efficacy of aerosolized SF-RI 1 (AeroFact) when delivered via nCPAP at two ...

  9. A Study To Evaluate The Adverse Events, And Efficacy Of Intravenous (IV) Of Telisotuzumab Adizutecan In Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab In Adult Participants With Metastatic Colorectal Cancer - Mayo Clinic

    This study will be divided into two stages, with the first stage treating participants with increasing doses of telisotuzumab adizutecan with FOLFOX and ...

  10. Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...